Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis

Nobunori Takahashi,Toshihisa Kojima,Daihei Kida,Atsushi Kaneko,Yuji Hirano,Takayoshi Fujibayashi,Yuichiro Yabe,Hideki Takagi,Takeshi Oguchi,M. Hanabayashi,Takefumi Kato,Koji Funahashi,Masatoshi Hayashi,Seiji Tsuboi,Yasuhide Kanayama,Yasumori Sobue,Nobuyuki Asai,Takuya Matsumoto,Tatsuo Watanabe,Shuji Asai,Naoki Ishiguro

Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis

2019

Objective To compare the clinical outcomes of abatacept between rheumatoid arthritis patients with and without concomitant methotrexate (MTX) treatment in daily clinical practice.

Keywords:

Abatacept
Methotrexate
Diabetes mellitus
Physical therapy
Rheumatoid arthritis
Propensity score matching
Internal medicine
Medicine
Concomitant
Rheumatology
Concomitant drug
Rheumatism

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations